N. Hanania, A. Papi, A. Anzueto, F. J. Martinez, K. Rossman, C. Cappelletti, E. A. Duncan, J. Nyberg, P. Dorinsky
{"title":"布地奈德/富马酸福莫特罗计量吸入器(BFF MDI)与富马酸福莫特罗(FF) MDI治疗COPD (SOPHOS)的12-52周随机双盲研究","authors":"N. Hanania, A. Papi, A. Anzueto, F. J. Martinez, K. Rossman, C. Cappelletti, E. A. Duncan, J. Nyberg, P. Dorinsky","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A 12-52 Week (Variable Length) Randomized Double-Blind Study of Budesonide/Formoterol Fumarate Metered Dose Inhaler (BFF MDI) Compared with Formoterol Fumarate (FF) MDI in COPD (SOPHOS)\",\"authors\":\"N. Hanania, A. Papi, A. Anzueto, F. J. Martinez, K. Rossman, C. Cappelletti, E. A. Duncan, J. Nyberg, P. Dorinsky\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":371205,\"journal\":{\"name\":\"A102. COPD: THERAPY\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A102. COPD: THERAPY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A102. COPD: THERAPY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A 12-52 Week (Variable Length) Randomized Double-Blind Study of Budesonide/Formoterol Fumarate Metered Dose Inhaler (BFF MDI) Compared with Formoterol Fumarate (FF) MDI in COPD (SOPHOS)